Akari Therapeutics (AKTX) Institutional Ownership

+0.04 (+3.39%)
(As of 04/23/2024 ET)

Institutional Ownership Changes (13F Filings) for Akari Therapeutics (NASDAQ:AKTX)

Institutional Ownership
Number of
Institutional Buyers
(last 12 months)
Institutional Inflows
(last 12 months)
Number of
Institutional Sellers
(last 12 months)
Institutional Outflows
(last 12 months)
Get AKTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akari Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AKTX Institutional Buying and Selling by Quarter

Akari Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/5/2024Omnia Family Wealth LLC87,628$273K0.1%+48.2%1.551%
11/15/2023Sabby Management LLC178,091$703K0.5%-97.6%3.152%
11/14/2022Armistice Capital LLC4,290,000$2.70M0.0%N/A5.762%
10/27/2022Omnia Family Wealth LLC782,372$493K0.4%+3.2%1.051%
5/6/2022Omnia Family Wealth LLC758,144$910K0.6%+13.7%1.277%
4/13/2022Hikari Power Ltd130,821$157K0.0%+45.7%0.220%
2/10/2022Wsfs Capital Management LLC100,000$150K0.1%N/A0.193%
2/4/2022Omnia Family Wealth LLC667,085$1.00M0.6%+42.8%1.285%
8/13/2021Renaissance Technologies LLC151,396$262K0.0%+14.0%0.318%
8/6/2021HighTower Advisors LLC26,000$45K0.0%N/A0.055%
8/3/2021Omnia Family Wealth LLC467,085$808K0.5%+12.1%0.981%
5/21/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175%
5/18/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175%
5/17/2021HRT Financial LP16,087$42K0.0%N/A0.101%
5/13/2021Renaissance Technologies LLC132,751$350K0.0%+23.3%0.837%
5/12/2021Geode Capital Management LLC30,264$79K0.0%N/A0.191%
5/12/2021Omnia Family Wealth LLC416,584$1.10M0.8%+6.4%2.627%
2/16/2021Endurant Capital Management LP206,561$382K0.1%N/A1.303%
2/10/2021HighTower Advisors LLC26,000$49K0.0%+62.5%0.164%
11/3/2020United Asset Strategies Inc.286,611$499K0.1%-4.5%1.807%
10/20/2020Wedbush Securities Inc.31,381$55K0.0%N/A0.198%
10/8/2020Hikari Power Ltd89,815$156K0.0%-94.0%0.566%
8/28/2020PNC Financial Services Group Inc.12,000$26K0.0%N/A0.076%
8/7/2020Virtu Financial LLC18,129$40K0.0%N/A0.114%
8/7/2020PNC Financial Services Group Inc.12,000$26K0.0%N/A0.076%
8/3/2020United Asset Strategies Inc.300,000$654K0.1%N/A1.892%
5/5/2020Omnia Family Wealth LLC184,258$267K0.3%+8.6%1.162%
(Data available from 1/1/2016 forward)

AKTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AKTX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Akari Therapeutics shares: Armistice Capital LLC ($2.70M), and Sabby Management LLC ($703K), Omnia Family Wealth LLC ($273K).Learn more on AKTX's institutional investors.

What percentage of Akari Therapeutics stock is owned by institutional investors?

5.06% of Akari Therapeutics stock is owned by institutional investors. Learn more on AKTX's institutional investor holdings.

Which institutional investors have been buying Akari Therapeutics stock?

The following institutional investors have purchased Akari Therapeutics stock in the last 24 months: Armistice Capital LLC ($4.29M), and Omnia Family Wealth LLC ($143.80K).

How much institutional buying is happening at Akari Therapeutics?

Institutional investors have bought a total of 4,433,798 shares in the last 24 months. This purchase volume represents approximately $56.63M in transactions.

Which Akari Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Akari Therapeutics stock in the last 24 months: Sabby Management LLC ($7.21M).

How much institutional selling is happening at Akari Therapeutics?

Institutional investors have sold a total of 7,214,040 shares in the last 24 months. This volume of shares sold represents approximately $28.50M in transactions.

This page (NASDAQ:AKTX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners